These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27118123)

  • 41. Evaluating heterogeneity in indoor and outdoor air pollution using land-use regression and constrained factor analysis.
    Levy JI; Clougherty JE; Baxter LK; Houseman EA; Paciorek CJ;
    Res Rep Health Eff Inst; 2010 Dec; (152):5-80; discussion 81-91. PubMed ID: 21409949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. L1 penalized estimation in the Cox proportional hazards model.
    Goeman JJ
    Biom J; 2010 Feb; 52(1):70-84. PubMed ID: 19937997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allowing for mandatory covariates in boosting estimation of sparse high-dimensional survival models.
    Binder H; Schumacher M
    BMC Bioinformatics; 2008 Jan; 9():14. PubMed ID: 18186927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AucPR: an AUC-based approach using penalized regression for disease prediction with high-dimensional omics data.
    Yu W; Park T
    BMC Genomics; 2014; 15 Suppl 10(Suppl 10):S1. PubMed ID: 25559769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An overview of techniques for linking high-dimensional molecular data to time-to-event endpoints by risk prediction models.
    Binder H; Porzelius C; Schumacher M
    Biom J; 2011 Mar; 53(2):170-89. PubMed ID: 21328602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coupled variable selection for regression modeling of complex treatment patterns in a clinical cancer registry.
    Schmidtmann I; Elsäßer A; Weinmann A; Binder H
    Stat Med; 2014 Dec; 33(30):5358-70. PubMed ID: 25345575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meta-analysis for aggregated survival data with competing risks: a parametric approach using cumulative incidence functions.
    Bonofiglio F; Beyersmann J; Schumacher M; Koller M; Schwarzer G
    Res Synth Methods; 2016 Sep; 7(3):282-93. PubMed ID: 26387882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modelling two cause-specific hazards of competing risks in one cumulative proportional odds model?
    Ohneberg K; Schumacher M; Beyersmann J
    Stat Med; 2017 Nov; 36(27):4353-4363. PubMed ID: 28833435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data.
    Rosthøj S; Andersen PK; Abildstrom SZ
    Comput Methods Programs Biomed; 2004 Apr; 74(1):69-75. PubMed ID: 14992828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.
    Varadhan R; Weiss CO; Segal JB; Wu AW; Scharfstein D; Boyd C
    Med Care; 2010 Jun; 48(6 Suppl):S96-105. PubMed ID: 20473207
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Considerations for analysis of time-to-event outcomes subject to competing risks in veterinary clinical studies.
    Oyama MA; Shaw PA; Ellenberg SS
    J Vet Cardiol; 2018 Jun; 20(3):143-153. PubMed ID: 29680637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Penalized estimation of frailty-based illness-death models for semi-competing risks.
    Reeder HT; Lu J; Haneuse S
    Biometrics; 2023 Sep; 79(3):1657-1669. PubMed ID: 36125235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Model building in nonproportional hazard regression.
    Rodríguez-Girondo M; Kneib T; Cadarso-Suárez C; Abu-Assi E
    Stat Med; 2013 Dec; 32(30):5301-14. PubMed ID: 24038401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.
    Rauch G; Kieser M; Ulrich S; Doherty P; Rauch B; Schneider S; Riemer T; Senges J
    Eur J Prev Cardiol; 2014 Jan; 21(1):74-80. PubMed ID: 22964966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Penalized gaussian process regression and classification for high-dimensional nonlinear data.
    Yi G; Shi JQ; Choi T
    Biometrics; 2011 Dec; 67(4):1285-94. PubMed ID: 21385168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
    Kim D; Li R; Dudek SM; Ritchie MD
    J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modeling cumulative incidence function for competing risks data.
    Zhang MJ; Zhang X; Scheike TH
    Expert Rev Clin Pharmacol; 2008 May; 1(3):391-400. PubMed ID: 19829754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Semiparametric regression on cumulative incidence function with interval-censored competing risks data.
    Bakoyannis G; Yu M; Yiannoutsos CT
    Stat Med; 2017 Oct; 36(23):3683-3707. PubMed ID: 28608412
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Penalized item response theory models: application to epigenetic alterations in bladder cancer.
    Houseman EA; Marsit C; Karagas M; Ryan LM
    Biometrics; 2007 Dec; 63(4):1269-77. PubMed ID: 17484774
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survival studies: competing risks, immortality and censoring.
    Barnett AG; Oldmeadow C; Attia JR
    Med J Aust; 2018 Jun; 208(11):475-477. PubMed ID: 29902402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.